?-Nicotinamide Mononucleotide (NMN) Industry Research Report 2023
Highlights
The global ?-Nicotinamide Mononucleotide (NMN) market is projected to reach US$ million by 2029 from an estimated US$ million in 2022, at a CAGR of % during 2023 and 2029.
North American market for ?-Nicotinamide Mononucleotide (NMN) is estimated to increase from $ million in 2022 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for ?-Nicotinamide Mononucleotide (NMN) is estimated to increase from $ million in 2022 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The major global companies of ?-Nicotinamide Mononucleotide (NMN) include GeneHarbor, Herbalmax, Genex Formulas, Shinkowa Pharmaceutical, Maac10 Formulas, EffePharm, Bontac, CELFULL and Kingdomway, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
The global market for ?-Nicotinamide Mononucleotide (NMN) in Health Care Products is estimated to increase from $ million in 2022 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, Above 98%, which accounted for % of the global market of ?-Nicotinamide Mononucleotide (NMN) in 2022, is expected to reach million US$ by 2029, growing at a revised CAGR of % from 2023 to 2029.
Report Scope
This report aims to provide a comprehensive presentation of the global market for ?-Nicotinamide Mononucleotide (NMN), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding ?-Nicotinamide Mononucleotide (NMN).
The ?-Nicotinamide Mononucleotide (NMN) market size, estimations, and forecasts are provided in terms of output/shipments (Kg) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global ?-Nicotinamide Mononucleotide (NMN) market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the ?-Nicotinamide Mononucleotide (NMN) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2018-2023. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
Global markets are presented by ?-Nicotinamide Mononucleotide (NMN) content, along with growth forecasts through 2029. Estimates on production and value are based on the price in the supply chain at which the ?-Nicotinamide Mononucleotide (NMN) are procured by the manufacturers.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows production and revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
?-Nicotinamide Mononucleotide (NMN) segment by Content
This report has provided the market size (production and revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the ?-Nicotinamide Mononucleotide (NMN) market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the ?-Nicotinamide Mononucleotide (NMN) market.
?-Nicotinamide Mononucleotide (NMN) segment by Application
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2022 because of the base year, with estimates for 2023 and forecast value for 2029.
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the ?-Nicotinamide Mononucleotide (NMN) market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global ?-Nicotinamide Mononucleotide (NMN) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of ?-Nicotinamide Mononucleotide (NMN) and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the ?-Nicotinamide Mononucleotide (NMN) industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of ?-Nicotinamide Mononucleotide (NMN).
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of ?-Nicotinamide Mononucleotide (NMN) manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of ?-Nicotinamide Mononucleotide (NMN) by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of ?-Nicotinamide Mononucleotide (NMN) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by content, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
The global ?-Nicotinamide Mononucleotide (NMN) market is projected to reach US$ million by 2029 from an estimated US$ million in 2022, at a CAGR of % during 2023 and 2029.
North American market for ?-Nicotinamide Mononucleotide (NMN) is estimated to increase from $ million in 2022 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for ?-Nicotinamide Mononucleotide (NMN) is estimated to increase from $ million in 2022 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The major global companies of ?-Nicotinamide Mononucleotide (NMN) include GeneHarbor, Herbalmax, Genex Formulas, Shinkowa Pharmaceutical, Maac10 Formulas, EffePharm, Bontac, CELFULL and Kingdomway, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
The global market for ?-Nicotinamide Mononucleotide (NMN) in Health Care Products is estimated to increase from $ million in 2022 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, Above 98%, which accounted for % of the global market of ?-Nicotinamide Mononucleotide (NMN) in 2022, is expected to reach million US$ by 2029, growing at a revised CAGR of % from 2023 to 2029.
Report Scope
This report aims to provide a comprehensive presentation of the global market for ?-Nicotinamide Mononucleotide (NMN), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding ?-Nicotinamide Mononucleotide (NMN).
The ?-Nicotinamide Mononucleotide (NMN) market size, estimations, and forecasts are provided in terms of output/shipments (Kg) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global ?-Nicotinamide Mononucleotide (NMN) market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the ?-Nicotinamide Mononucleotide (NMN) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2018-2023. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
- GeneHarbor
- Herbalmax
- Genex Formulas
- Shinkowa Pharmaceutical
- Maac10 Formulas
- EffePharm
- Bontac
- CELFULL
- Kingdomway
Global markets are presented by ?-Nicotinamide Mononucleotide (NMN) content, along with growth forecasts through 2029. Estimates on production and value are based on the price in the supply chain at which the ?-Nicotinamide Mononucleotide (NMN) are procured by the manufacturers.
This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows production and revenue data by type, and during the historical period (2018-2023) and forecast period (2024-2029).
?-Nicotinamide Mononucleotide (NMN) segment by Content
- Above 98%
- Below 98%
This report has provided the market size (production and revenue data) by application, during the historical period (2018-2023) and forecast period (2024-2029).
This report also outlines the market trends of each segment and consumer behaviors impacting the ?-Nicotinamide Mononucleotide (NMN) market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the ?-Nicotinamide Mononucleotide (NMN) market.
?-Nicotinamide Mononucleotide (NMN) segment by Application
- Health Care Products
- Cosmetics
- Others
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2018-2029.
The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2022 because of the base year, with estimates for 2023 and forecast value for 2029.
- North America
- United States
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the ?-Nicotinamide Mononucleotide (NMN) market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global ?-Nicotinamide Mononucleotide (NMN) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of ?-Nicotinamide Mononucleotide (NMN) and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the ?-Nicotinamide Mononucleotide (NMN) industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of ?-Nicotinamide Mononucleotide (NMN).
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of ?-Nicotinamide Mononucleotide (NMN) manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of ?-Nicotinamide Mononucleotide (NMN) by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of ?-Nicotinamide Mononucleotide (NMN) in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by content, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
1 PREFACE
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 ?-Nicotinamide Mononucleotide (NMN) by Content
2.2.1 Market Value Comparison by Content (2018 VS 2022 VS 2029) & (US$ Million)
1.2.2 Above 98%
1.2.3 Below 98%
2.3 ?-Nicotinamide Mononucleotide (NMN) by Application
2.3.1 Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
2.3.2 Health Care Products
2.3.3 Cosmetics
2.3.4 Others
2.4 Global Market Growth Prospects
2.4.1 Global ?-Nicotinamide Mononucleotide (NMN) Production Value Estimates and Forecasts (2018-2029)
2.4.2 Global ?-Nicotinamide Mononucleotide (NMN) Production Capacity Estimates and Forecasts (2018-2029)
2.4.3 Global ?-Nicotinamide Mononucleotide (NMN) Production Estimates and Forecasts (2018-2029)
2.4.4 Global ?-Nicotinamide Mononucleotide (NMN) Market Average Price (2018-2029)
3 MARKET COMPETITIVE LANDSCAPE BY MANUFACTURERS
3.1 Global ?-Nicotinamide Mononucleotide (NMN) Production by Manufacturers (2018-2023)
3.2 Global ?-Nicotinamide Mononucleotide (NMN) Production Value by Manufacturers (2018-2023)
3.3 Global ?-Nicotinamide Mononucleotide (NMN) Average Price by Manufacturers (2018-2023)
3.4 Global ?-Nicotinamide Mononucleotide (NMN) Industry Manufacturers Ranking, 2021 VS 2022 VS 2023
3.5 Global ?-Nicotinamide Mononucleotide (NMN) Key Manufacturers, Manufacturing Sites & Headquarters
3.6 Global ?-Nicotinamide Mononucleotide (NMN) Manufacturers, Product Type & Application
3.7 Global ?-Nicotinamide Mononucleotide (NMN) Manufacturers, Date of Enter into This Industry
3.8 Global ?-Nicotinamide Mononucleotide (NMN) Market CR5 and HHI
3.9 Global Manufacturers Mergers & Acquisition
4 MANUFACTURERS PROFILED
4.1 GeneHarbor
4.1.1 GeneHarbor ?-Nicotinamide Mononucleotide (NMN) Company Information
4.1.2 GeneHarbor ?-Nicotinamide Mononucleotide (NMN) Business Overview
4.1.3 GeneHarbor ?-Nicotinamide Mononucleotide (NMN) Production Capacity, Value and Gross Margin (2018-2023)
4.1.4 GeneHarbor Product Portfolio
4.1.5 GeneHarbor Recent Developments
4.2 Herbalmax
4.2.1 Herbalmax ?-Nicotinamide Mononucleotide (NMN) Company Information
4.2.2 Herbalmax ?-Nicotinamide Mononucleotide (NMN) Business Overview
4.2.3 Herbalmax ?-Nicotinamide Mononucleotide (NMN) Production Capacity, Value and Gross Margin (2018-2023)
4.2.4 Herbalmax Product Portfolio
4.2.5 Herbalmax Recent Developments
4.3 Genex Formulas
4.3.1 Genex Formulas ?-Nicotinamide Mononucleotide (NMN) Company Information
4.3.2 Genex Formulas ?-Nicotinamide Mononucleotide (NMN) Business Overview
4.3.3 Genex Formulas ?-Nicotinamide Mononucleotide (NMN) Production Capacity, Value and Gross Margin (2018-2023)
4.3.4 Genex Formulas Product Portfolio
4.3.5 Genex Formulas Recent Developments
4.4 Shinkowa Pharmaceutical
4.4.1 Shinkowa Pharmaceutical ?-Nicotinamide Mononucleotide (NMN) Company Information
4.4.2 Shinkowa Pharmaceutical ?-Nicotinamide Mononucleotide (NMN) Business Overview
4.4.3 Shinkowa Pharmaceutical ?-Nicotinamide Mononucleotide (NMN) Production Capacity, Value and Gross Margin (2018-2023)
4.4.4 Shinkowa Pharmaceutical Product Portfolio
4.4.5 Shinkowa Pharmaceutical Recent Developments
4.5 Maac10 Formulas
4.5.1 Maac10 Formulas ?-Nicotinamide Mononucleotide (NMN) Company Information
4.5.2 Maac10 Formulas ?-Nicotinamide Mononucleotide (NMN) Business Overview
4.5.3 Maac10 Formulas ?-Nicotinamide Mononucleotide (NMN) Production Capacity, Value and Gross Margin (2018-2023)
4.5.4 Maac10 Formulas Product Portfolio
4.5.5 Maac10 Formulas Recent Developments
4.6 EffePharm
4.6.1 EffePharm ?-Nicotinamide Mononucleotide (NMN) Company Information
4.6.2 EffePharm ?-Nicotinamide Mononucleotide (NMN) Business Overview
4.6.3 EffePharm ?-Nicotinamide Mononucleotide (NMN) Production Capacity, Value and Gross Margin (2018-2023)
4.6.4 EffePharm Product Portfolio
4.6.5 EffePharm Recent Developments
4.7 Bontac
4.7.1 Bontac ?-Nicotinamide Mononucleotide (NMN) Company Information
4.7.2 Bontac ?-Nicotinamide Mononucleotide (NMN) Business Overview
4.7.3 Bontac ?-Nicotinamide Mononucleotide (NMN) Production Capacity, Value and Gross Margin (2018-2023)
4.7.4 Bontac Product Portfolio
4.7.5 Bontac Recent Developments
4.8 CELFULL
4.8.1 CELFULL ?-Nicotinamide Mononucleotide (NMN) Company Information
4.8.2 CELFULL ?-Nicotinamide Mononucleotide (NMN) Business Overview
4.8.3 CELFULL ?-Nicotinamide Mononucleotide (NMN) Production Capacity, Value and Gross Margin (2018-2023)
4.8.4 CELFULL Product Portfolio
4.8.5 CELFULL Recent Developments
4.9 Kingdomway
4.9.1 Kingdomway ?-Nicotinamide Mononucleotide (NMN) Company Information
4.9.2 Kingdomway ?-Nicotinamide Mononucleotide (NMN) Business Overview
4.9.3 Kingdomway ?-Nicotinamide Mononucleotide (NMN) Production Capacity, Value and Gross Margin (2018-2023)
4.9.4 Kingdomway Product Portfolio
4.9.5 Kingdomway Recent Developments
5 GLOBAL ?-NICOTINAMIDE MONONUCLEOTIDE (NMN) PRODUCTION BY REGION
5.1 Global ?-Nicotinamide Mononucleotide (NMN) Production Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
5.2 Global ?-Nicotinamide Mononucleotide (NMN) Production by Region: 2018-2029
5.2.1 Global ?-Nicotinamide Mononucleotide (NMN) Production by Region: 2018-2023
5.2.2 Global ?-Nicotinamide Mononucleotide (NMN) Production Forecast by Region (2024-2029)
5.3 Global ?-Nicotinamide Mononucleotide (NMN) Production Value Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
5.4 Global ?-Nicotinamide Mononucleotide (NMN) Production Value by Region: 2018-2029
5.4.1 Global ?-Nicotinamide Mononucleotide (NMN) Production Value by Region: 2018-2023
5.4.2 Global ?-Nicotinamide Mononucleotide (NMN) Production Value Forecast by Region (2024-2029)
5.5 Global ?-Nicotinamide Mononucleotide (NMN) Market Price Analysis by Region (2018-2023)
5.6 Global ?-Nicotinamide Mononucleotide (NMN) Production and Value, YOY Growth
5.6.1 North America ?-Nicotinamide Mononucleotide (NMN) Production Value Estimates and Forecasts (2018-2029)
5.6.2 Europe ?-Nicotinamide Mononucleotide (NMN) Production Value Estimates and Forecasts (2018-2029)
5.6.3 China ?-Nicotinamide Mononucleotide (NMN) Production Value Estimates and Forecasts (2018-2029)
5.6.4 Japan ?-Nicotinamide Mononucleotide (NMN) Production Value Estimates and Forecasts (2018-2029)
6 GLOBAL ?-NICOTINAMIDE MONONUCLEOTIDE (NMN) CONSUMPTION BY REGION
6.1 Global ?-Nicotinamide Mononucleotide (NMN) Consumption Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
6.2 Global ?-Nicotinamide Mononucleotide (NMN) Consumption by Region (2018-2029)
6.2.1 Global ?-Nicotinamide Mononucleotide (NMN) Consumption by Region: 2018-2029
6.2.2 Global ?-Nicotinamide Mononucleotide (NMN) Forecasted Consumption by Region (2024-2029)
6.3 North America
6.3.1 North America ?-Nicotinamide Mononucleotide (NMN) Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
6.3.2 North America ?-Nicotinamide Mononucleotide (NMN) Consumption by Country (2018-2029)
6.3.3 United States
6.3.4 Canada
6.4 Europe
6.4.1 Europe ?-Nicotinamide Mononucleotide (NMN) Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
6.4.2 Europe ?-Nicotinamide Mononucleotide (NMN) Consumption by Country (2018-2029)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Russia
6.5 Asia Pacific
6.5.1 Asia Pacific ?-Nicotinamide Mononucleotide (NMN) Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
6.5.2 Asia Pacific ?-Nicotinamide Mononucleotide (NMN) Consumption by Country (2018-2029)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 China Taiwan
6.5.7 Southeast Asia
6.5.8 India
6.5.9 Australia
6.6 Latin America, Middle East & Africa
6.6.1 Latin America, Middle East & Africa ?-Nicotinamide Mononucleotide (NMN) Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
6.6.2 Latin America, Middle East & Africa ?-Nicotinamide Mononucleotide (NMN) Consumption by Country (2018-2029)
6.6.3 Mexico
6.6.4 Brazil
6.6.5 Turkey
6.6.5 GCC Countries
7 SEGMENT BY CONTENT
7.1 Global ?-Nicotinamide Mononucleotide (NMN) Production by Content (2018-2029)
7.1.1 Global ?-Nicotinamide Mononucleotide (NMN) Production by Content (2018-2029) & (Kg)
7.1.2 Global ?-Nicotinamide Mononucleotide (NMN) Production Market Share by Content (2018-2029)
7.2 Global ?-Nicotinamide Mononucleotide (NMN) Production Value by Content (2018-2029)
7.2.1 Global ?-Nicotinamide Mononucleotide (NMN) Production Value by Content (2018-2029) & (US$ Million)
7.2.2 Global ?-Nicotinamide Mononucleotide (NMN) Production Value Market Share by Content (2018-2029)
7.3 Global ?-Nicotinamide Mononucleotide (NMN) Price by Content (2018-2029)
8 SEGMENT BY APPLICATION
8.1 Global ?-Nicotinamide Mononucleotide (NMN) Production by Application (2018-2029)
8.1.1 Global ?-Nicotinamide Mononucleotide (NMN) Production by Application (2018-2029) & (Kg)
8.1.2 Global ?-Nicotinamide Mononucleotide (NMN) Production by Application (2018-2029) & (Kg)
8.2 Global ?-Nicotinamide Mononucleotide (NMN) Production Value by Application (2018-2029)
8.2.1 Global ?-Nicotinamide Mononucleotide (NMN) Production Value by Application (2018-2029) & (US$ Million)
8.2.2 Global ?-Nicotinamide Mononucleotide (NMN) Production Value Market Share by Application (2018-2029)
8.3 Global ?-Nicotinamide Mononucleotide (NMN) Price by Application (2018-2029)
9 VALUE CHAIN AND SALES CHANNELS ANALYSIS OF THE MARKET
9.1 ?-Nicotinamide Mononucleotide (NMN) Value Chain Analysis
9.1.1 ?-Nicotinamide Mononucleotide (NMN) Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 ?-Nicotinamide Mononucleotide (NMN) Production Mode & Process
9.2 ?-Nicotinamide Mononucleotide (NMN) Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 ?-Nicotinamide Mononucleotide (NMN) Distributors
9.2.3 ?-Nicotinamide Mononucleotide (NMN) Customers
10 GLOBAL ?-NICOTINAMIDE MONONUCLEOTIDE (NMN) ANALYZING MARKET DYNAMICS
10.1 ?-Nicotinamide Mononucleotide (NMN) Industry Trends
10.2 ?-Nicotinamide Mononucleotide (NMN) Industry Drivers
10.3 ?-Nicotinamide Mononucleotide (NMN) Industry Opportunities and Challenges
10.4 ?-Nicotinamide Mononucleotide (NMN) Industry Restraints
11 REPORT CONCLUSION
12 DISCLAIMER
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 MARKET OVERVIEW
2.1 Product Definition
2.2 ?-Nicotinamide Mononucleotide (NMN) by Content
2.2.1 Market Value Comparison by Content (2018 VS 2022 VS 2029) & (US$ Million)
1.2.2 Above 98%
1.2.3 Below 98%
2.3 ?-Nicotinamide Mononucleotide (NMN) by Application
2.3.1 Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
2.3.2 Health Care Products
2.3.3 Cosmetics
2.3.4 Others
2.4 Global Market Growth Prospects
2.4.1 Global ?-Nicotinamide Mononucleotide (NMN) Production Value Estimates and Forecasts (2018-2029)
2.4.2 Global ?-Nicotinamide Mononucleotide (NMN) Production Capacity Estimates and Forecasts (2018-2029)
2.4.3 Global ?-Nicotinamide Mononucleotide (NMN) Production Estimates and Forecasts (2018-2029)
2.4.4 Global ?-Nicotinamide Mononucleotide (NMN) Market Average Price (2018-2029)
3 MARKET COMPETITIVE LANDSCAPE BY MANUFACTURERS
3.1 Global ?-Nicotinamide Mononucleotide (NMN) Production by Manufacturers (2018-2023)
3.2 Global ?-Nicotinamide Mononucleotide (NMN) Production Value by Manufacturers (2018-2023)
3.3 Global ?-Nicotinamide Mononucleotide (NMN) Average Price by Manufacturers (2018-2023)
3.4 Global ?-Nicotinamide Mononucleotide (NMN) Industry Manufacturers Ranking, 2021 VS 2022 VS 2023
3.5 Global ?-Nicotinamide Mononucleotide (NMN) Key Manufacturers, Manufacturing Sites & Headquarters
3.6 Global ?-Nicotinamide Mononucleotide (NMN) Manufacturers, Product Type & Application
3.7 Global ?-Nicotinamide Mononucleotide (NMN) Manufacturers, Date of Enter into This Industry
3.8 Global ?-Nicotinamide Mononucleotide (NMN) Market CR5 and HHI
3.9 Global Manufacturers Mergers & Acquisition
4 MANUFACTURERS PROFILED
4.1 GeneHarbor
4.1.1 GeneHarbor ?-Nicotinamide Mononucleotide (NMN) Company Information
4.1.2 GeneHarbor ?-Nicotinamide Mononucleotide (NMN) Business Overview
4.1.3 GeneHarbor ?-Nicotinamide Mononucleotide (NMN) Production Capacity, Value and Gross Margin (2018-2023)
4.1.4 GeneHarbor Product Portfolio
4.1.5 GeneHarbor Recent Developments
4.2 Herbalmax
4.2.1 Herbalmax ?-Nicotinamide Mononucleotide (NMN) Company Information
4.2.2 Herbalmax ?-Nicotinamide Mononucleotide (NMN) Business Overview
4.2.3 Herbalmax ?-Nicotinamide Mononucleotide (NMN) Production Capacity, Value and Gross Margin (2018-2023)
4.2.4 Herbalmax Product Portfolio
4.2.5 Herbalmax Recent Developments
4.3 Genex Formulas
4.3.1 Genex Formulas ?-Nicotinamide Mononucleotide (NMN) Company Information
4.3.2 Genex Formulas ?-Nicotinamide Mononucleotide (NMN) Business Overview
4.3.3 Genex Formulas ?-Nicotinamide Mononucleotide (NMN) Production Capacity, Value and Gross Margin (2018-2023)
4.3.4 Genex Formulas Product Portfolio
4.3.5 Genex Formulas Recent Developments
4.4 Shinkowa Pharmaceutical
4.4.1 Shinkowa Pharmaceutical ?-Nicotinamide Mononucleotide (NMN) Company Information
4.4.2 Shinkowa Pharmaceutical ?-Nicotinamide Mononucleotide (NMN) Business Overview
4.4.3 Shinkowa Pharmaceutical ?-Nicotinamide Mononucleotide (NMN) Production Capacity, Value and Gross Margin (2018-2023)
4.4.4 Shinkowa Pharmaceutical Product Portfolio
4.4.5 Shinkowa Pharmaceutical Recent Developments
4.5 Maac10 Formulas
4.5.1 Maac10 Formulas ?-Nicotinamide Mononucleotide (NMN) Company Information
4.5.2 Maac10 Formulas ?-Nicotinamide Mononucleotide (NMN) Business Overview
4.5.3 Maac10 Formulas ?-Nicotinamide Mononucleotide (NMN) Production Capacity, Value and Gross Margin (2018-2023)
4.5.4 Maac10 Formulas Product Portfolio
4.5.5 Maac10 Formulas Recent Developments
4.6 EffePharm
4.6.1 EffePharm ?-Nicotinamide Mononucleotide (NMN) Company Information
4.6.2 EffePharm ?-Nicotinamide Mononucleotide (NMN) Business Overview
4.6.3 EffePharm ?-Nicotinamide Mononucleotide (NMN) Production Capacity, Value and Gross Margin (2018-2023)
4.6.4 EffePharm Product Portfolio
4.6.5 EffePharm Recent Developments
4.7 Bontac
4.7.1 Bontac ?-Nicotinamide Mononucleotide (NMN) Company Information
4.7.2 Bontac ?-Nicotinamide Mononucleotide (NMN) Business Overview
4.7.3 Bontac ?-Nicotinamide Mononucleotide (NMN) Production Capacity, Value and Gross Margin (2018-2023)
4.7.4 Bontac Product Portfolio
4.7.5 Bontac Recent Developments
4.8 CELFULL
4.8.1 CELFULL ?-Nicotinamide Mononucleotide (NMN) Company Information
4.8.2 CELFULL ?-Nicotinamide Mononucleotide (NMN) Business Overview
4.8.3 CELFULL ?-Nicotinamide Mononucleotide (NMN) Production Capacity, Value and Gross Margin (2018-2023)
4.8.4 CELFULL Product Portfolio
4.8.5 CELFULL Recent Developments
4.9 Kingdomway
4.9.1 Kingdomway ?-Nicotinamide Mononucleotide (NMN) Company Information
4.9.2 Kingdomway ?-Nicotinamide Mononucleotide (NMN) Business Overview
4.9.3 Kingdomway ?-Nicotinamide Mononucleotide (NMN) Production Capacity, Value and Gross Margin (2018-2023)
4.9.4 Kingdomway Product Portfolio
4.9.5 Kingdomway Recent Developments
5 GLOBAL ?-NICOTINAMIDE MONONUCLEOTIDE (NMN) PRODUCTION BY REGION
5.1 Global ?-Nicotinamide Mononucleotide (NMN) Production Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
5.2 Global ?-Nicotinamide Mononucleotide (NMN) Production by Region: 2018-2029
5.2.1 Global ?-Nicotinamide Mononucleotide (NMN) Production by Region: 2018-2023
5.2.2 Global ?-Nicotinamide Mononucleotide (NMN) Production Forecast by Region (2024-2029)
5.3 Global ?-Nicotinamide Mononucleotide (NMN) Production Value Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
5.4 Global ?-Nicotinamide Mononucleotide (NMN) Production Value by Region: 2018-2029
5.4.1 Global ?-Nicotinamide Mononucleotide (NMN) Production Value by Region: 2018-2023
5.4.2 Global ?-Nicotinamide Mononucleotide (NMN) Production Value Forecast by Region (2024-2029)
5.5 Global ?-Nicotinamide Mononucleotide (NMN) Market Price Analysis by Region (2018-2023)
5.6 Global ?-Nicotinamide Mononucleotide (NMN) Production and Value, YOY Growth
5.6.1 North America ?-Nicotinamide Mononucleotide (NMN) Production Value Estimates and Forecasts (2018-2029)
5.6.2 Europe ?-Nicotinamide Mononucleotide (NMN) Production Value Estimates and Forecasts (2018-2029)
5.6.3 China ?-Nicotinamide Mononucleotide (NMN) Production Value Estimates and Forecasts (2018-2029)
5.6.4 Japan ?-Nicotinamide Mononucleotide (NMN) Production Value Estimates and Forecasts (2018-2029)
6 GLOBAL ?-NICOTINAMIDE MONONUCLEOTIDE (NMN) CONSUMPTION BY REGION
6.1 Global ?-Nicotinamide Mononucleotide (NMN) Consumption Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
6.2 Global ?-Nicotinamide Mononucleotide (NMN) Consumption by Region (2018-2029)
6.2.1 Global ?-Nicotinamide Mononucleotide (NMN) Consumption by Region: 2018-2029
6.2.2 Global ?-Nicotinamide Mononucleotide (NMN) Forecasted Consumption by Region (2024-2029)
6.3 North America
6.3.1 North America ?-Nicotinamide Mononucleotide (NMN) Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
6.3.2 North America ?-Nicotinamide Mononucleotide (NMN) Consumption by Country (2018-2029)
6.3.3 United States
6.3.4 Canada
6.4 Europe
6.4.1 Europe ?-Nicotinamide Mononucleotide (NMN) Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
6.4.2 Europe ?-Nicotinamide Mononucleotide (NMN) Consumption by Country (2018-2029)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Russia
6.5 Asia Pacific
6.5.1 Asia Pacific ?-Nicotinamide Mononucleotide (NMN) Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
6.5.2 Asia Pacific ?-Nicotinamide Mononucleotide (NMN) Consumption by Country (2018-2029)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 China Taiwan
6.5.7 Southeast Asia
6.5.8 India
6.5.9 Australia
6.6 Latin America, Middle East & Africa
6.6.1 Latin America, Middle East & Africa ?-Nicotinamide Mononucleotide (NMN) Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
6.6.2 Latin America, Middle East & Africa ?-Nicotinamide Mononucleotide (NMN) Consumption by Country (2018-2029)
6.6.3 Mexico
6.6.4 Brazil
6.6.5 Turkey
6.6.5 GCC Countries
7 SEGMENT BY CONTENT
7.1 Global ?-Nicotinamide Mononucleotide (NMN) Production by Content (2018-2029)
7.1.1 Global ?-Nicotinamide Mononucleotide (NMN) Production by Content (2018-2029) & (Kg)
7.1.2 Global ?-Nicotinamide Mononucleotide (NMN) Production Market Share by Content (2018-2029)
7.2 Global ?-Nicotinamide Mononucleotide (NMN) Production Value by Content (2018-2029)
7.2.1 Global ?-Nicotinamide Mononucleotide (NMN) Production Value by Content (2018-2029) & (US$ Million)
7.2.2 Global ?-Nicotinamide Mononucleotide (NMN) Production Value Market Share by Content (2018-2029)
7.3 Global ?-Nicotinamide Mononucleotide (NMN) Price by Content (2018-2029)
8 SEGMENT BY APPLICATION
8.1 Global ?-Nicotinamide Mononucleotide (NMN) Production by Application (2018-2029)
8.1.1 Global ?-Nicotinamide Mononucleotide (NMN) Production by Application (2018-2029) & (Kg)
8.1.2 Global ?-Nicotinamide Mononucleotide (NMN) Production by Application (2018-2029) & (Kg)
8.2 Global ?-Nicotinamide Mononucleotide (NMN) Production Value by Application (2018-2029)
8.2.1 Global ?-Nicotinamide Mononucleotide (NMN) Production Value by Application (2018-2029) & (US$ Million)
8.2.2 Global ?-Nicotinamide Mononucleotide (NMN) Production Value Market Share by Application (2018-2029)
8.3 Global ?-Nicotinamide Mononucleotide (NMN) Price by Application (2018-2029)
9 VALUE CHAIN AND SALES CHANNELS ANALYSIS OF THE MARKET
9.1 ?-Nicotinamide Mononucleotide (NMN) Value Chain Analysis
9.1.1 ?-Nicotinamide Mononucleotide (NMN) Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 ?-Nicotinamide Mononucleotide (NMN) Production Mode & Process
9.2 ?-Nicotinamide Mononucleotide (NMN) Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 ?-Nicotinamide Mononucleotide (NMN) Distributors
9.2.3 ?-Nicotinamide Mononucleotide (NMN) Customers
10 GLOBAL ?-NICOTINAMIDE MONONUCLEOTIDE (NMN) ANALYZING MARKET DYNAMICS
10.1 ?-Nicotinamide Mononucleotide (NMN) Industry Trends
10.2 ?-Nicotinamide Mononucleotide (NMN) Industry Drivers
10.3 ?-Nicotinamide Mononucleotide (NMN) Industry Opportunities and Challenges
10.4 ?-Nicotinamide Mononucleotide (NMN) Industry Restraints
11 REPORT CONCLUSION
12 DISCLAIMER
LIST OF TABLES
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Content (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global ?-Nicotinamide Mononucleotide (NMN) Production by Manufacturers (Kg) & (2018-2023)
Table 6. Global ?-Nicotinamide Mononucleotide (NMN) Production Market Share by Manufacturers
Table 7. Global ?-Nicotinamide Mononucleotide (NMN) Production Value by Manufacturers (US$ Million) & (2018-2023)
Table 8. Global ?-Nicotinamide Mononucleotide (NMN) Production Value Market Share by Manufacturers (2018-2023)
Table 9. Global ?-Nicotinamide Mononucleotide (NMN) Average Price (US$/Kg) of Key Manufacturers (2018-2023)
Table 10. Global ?-Nicotinamide Mononucleotide (NMN) Industry Manufacturers Ranking, 2021 VS 2022 VS 2023
Table 11. Global ?-Nicotinamide Mononucleotide (NMN) Manufacturers, Product Type & Application
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global ?-Nicotinamide Mononucleotide (NMN) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value of 2022)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 15. GeneHarbor ?-Nicotinamide Mononucleotide (NMN) Company Information
Table 16. GeneHarbor Business Overview
Table 17. GeneHarbor ?-Nicotinamide Mononucleotide (NMN) Production Capacity (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 18. GeneHarbor Product Portfolio
Table 19. GeneHarbor Recent Developments
Table 20. Herbalmax ?-Nicotinamide Mononucleotide (NMN) Company Information
Table 21. Herbalmax Business Overview
Table 22. Herbalmax ?-Nicotinamide Mononucleotide (NMN) Production Capacity (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 23. Herbalmax Product Portfolio
Table 24. Herbalmax Recent Developments
Table 25. Genex Formulas ?-Nicotinamide Mononucleotide (NMN) Company Information
Table 26. Genex Formulas Business Overview
Table 27. Genex Formulas ?-Nicotinamide Mononucleotide (NMN) Production Capacity (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 28. Genex Formulas Product Portfolio
Table 29. Genex Formulas Recent Developments
Table 30. Shinkowa Pharmaceutical ?-Nicotinamide Mononucleotide (NMN) Company Information
Table 31. Shinkowa Pharmaceutical Business Overview
Table 32. Shinkowa Pharmaceutical ?-Nicotinamide Mononucleotide (NMN) Production Capacity (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 33. Shinkowa Pharmaceutical Product Portfolio
Table 34. Shinkowa Pharmaceutical Recent Developments
Table 35. Maac10 Formulas ?-Nicotinamide Mononucleotide (NMN) Company Information
Table 36. Maac10 Formulas Business Overview
Table 37. Maac10 Formulas ?-Nicotinamide Mononucleotide (NMN) Production Capacity (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 38. Maac10 Formulas Product Portfolio
Table 39. Maac10 Formulas Recent Developments
Table 40. EffePharm ?-Nicotinamide Mononucleotide (NMN) Company Information
Table 41. EffePharm Business Overview
Table 42. EffePharm ?-Nicotinamide Mononucleotide (NMN) Production Capacity (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 43. EffePharm Product Portfolio
Table 44. EffePharm Recent Developments
Table 45. Bontac ?-Nicotinamide Mononucleotide (NMN) Company Information
Table 46. Bontac Business Overview
Table 47. Bontac ?-Nicotinamide Mononucleotide (NMN) Production Capacity (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 48. Bontac Product Portfolio
Table 49. Bontac Recent Developments
Table 50. CELFULL ?-Nicotinamide Mononucleotide (NMN) Company Information
Table 51. CELFULL Business Overview
Table 52. CELFULL ?-Nicotinamide Mononucleotide (NMN) Production Capacity (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 53. CELFULL Product Portfolio
Table 54. CELFULL Recent Developments
Table 55. Kingdomway ?-Nicotinamide Mononucleotide (NMN) Company Information
Table 56. Kingdomway Business Overview
Table 57. Kingdomway ?-Nicotinamide Mononucleotide (NMN) Production Capacity (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 58. Kingdomway Product Portfolio
Table 59. Kingdomway Recent Developments
Table 60. Global ?-Nicotinamide Mononucleotide (NMN) Production Comparison by Region: 2018 VS 2022 VS 2029 (Kg)
Table 61. Global ?-Nicotinamide Mononucleotide (NMN) Production by Region (2018-2023) & (Kg)
Table 62. Global ?-Nicotinamide Mononucleotide (NMN) Production Market Share by Region (2018-2023)
Table 63. Global ?-Nicotinamide Mononucleotide (NMN) Production Forecast by Region (2024-2029) & (Kg)
Table 64. Global ?-Nicotinamide Mononucleotide (NMN) Production Market Share Forecast by Region (2024-2029)
Table 65. Global ?-Nicotinamide Mononucleotide (NMN) Production Value Comparison by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 66. Global ?-Nicotinamide Mononucleotide (NMN) Production Value by Region (2018-2023) & (US$ Million)
Table 67. Global ?-Nicotinamide Mononucleotide (NMN) Production Value Market Share by Region (2018-2023)
Table 68. Global ?-Nicotinamide Mononucleotide (NMN) Production Value Forecast by Region (2024-2029) & (US$ Million)
Table 69. Global ?-Nicotinamide Mononucleotide (NMN) Production Value Market Share Forecast by Region (2024-2029)
Table 70. Global ?-Nicotinamide Mononucleotide (NMN) Market Average Price (US$/Kg) by Region (2018-2023)
Table 71. Global ?-Nicotinamide Mononucleotide (NMN) Consumption Comparison by Region: 2018 VS 2022 VS 2029 (Kg)
Table 72. Global ?-Nicotinamide Mononucleotide (NMN) Consumption by Region (2018-2023) & (Kg)
Table 73. Global ?-Nicotinamide Mononucleotide (NMN) Consumption Market Share by Region (2018-2023)
Table 74. Global ?-Nicotinamide Mononucleotide (NMN) Forecasted Consumption by Region (2024-2029) & (Kg)
Table 75. Global ?-Nicotinamide Mononucleotide (NMN) Forecasted Consumption Market Share by Region (2024-2029)
Table 76. North America ?-Nicotinamide Mononucleotide (NMN) Consumption Growth Rate by Country: 2018 VS 2022 VS 2029 (Kg)
Table 77. North America ?-Nicotinamide Mononucleotide (NMN) Consumption by Country (2018-2023) & (Kg)
Table 78. North America ?-Nicotinamide Mononucleotide (NMN) Consumption by Country (2024-2029) & (Kg)
Table 79. Europe ?-Nicotinamide Mononucleotide (NMN) Consumption Growth Rate by Country: 2018 VS 2022 VS 2029 (Kg)
Table 80. Europe ?-Nicotinamide Mononucleotide (NMN) Consumption by Country (2018-2023) & (Kg)
Table 81. Europe ?-Nicotinamide Mononucleotide (NMN) Consumption by Country (2024-2029) & (Kg)
Table 82. Asia Pacific ?-Nicotinamide Mononucleotide (NMN) Consumption Growth Rate by Country: 2018 VS 2022 VS 2029 (Kg)
Table 83. Asia Pacific ?-Nicotinamide Mononucleotide (NMN) Consumption by Country (2018-2023) & (Kg)
Table 84. Asia Pacific ?-Nicotinamide Mononucleotide (NMN) Consumption by Country (2024-2029) & (Kg)
Table 85. Latin America, Middle East & Africa ?-Nicotinamide Mononucleotide (NMN) Consumption Growth Rate by Country: 2018 VS 2022 VS 2029 (Kg)
Table 86. Latin America, Middle East & Africa ?-Nicotinamide Mononucleotide (NMN) Consumption by Country (2018-2023) & (Kg)
Table 87. Latin America, Middle East & Africa ?-Nicotinamide Mononucleotide (NMN) Consumption by Country (2024-2029) & (Kg)
Table 88. Global ?-Nicotinamide Mononucleotide (NMN) Production by Content (2018-2023) & (Kg)
Table 89. Global ?-Nicotinamide Mononucleotide (NMN) Production by Content (2024-2029) & (Kg)
Table 90. Global ?-Nicotinamide Mononucleotide (NMN) Production Market Share by Content (2018-2023)
Table 91. Global ?-Nicotinamide Mononucleotide (NMN) Production Market Share by Content (2024-2029)
Table 92. Global ?-Nicotinamide Mononucleotide (NMN) Production Value by Content (2018-2023) & (US$ Million)
Table 93. Global ?-Nicotinamide Mononucleotide (NMN) Production Value by Content (2024-2029) & (US$ Million)
Table 94. Global ?-Nicotinamide Mononucleotide (NMN) Production Value Market Share by Content (2018-2023)
Table 95. Global ?-Nicotinamide Mononucleotide (NMN) Production Value Market Share by Content (2024-2029)
Table 96. Global ?-Nicotinamide Mononucleotide (NMN) Price by Content (2018-2023) & (US$/Kg)
Table 97. Global ?-Nicotinamide Mononucleotide (NMN) Price by Content (2024-2029) & (US$/Kg)
Table 98. Global ?-Nicotinamide Mononucleotide (NMN) Production by Application (2018-2023) & (Kg)
Table 99. Global ?-Nicotinamide Mononucleotide (NMN) Production by Application (2024-2029) & (Kg)
Table 100. Global ?-Nicotinamide Mononucleotide (NMN) Production Market Share by Application (2018-2023)
Table 101. Global ?-Nicotinamide Mononucleotide (NMN) Production Market Share by Application (2024-2029)
Table 102. Global ?-Nicotinamide Mononucleotide (NMN) Production Value by Application (2018-2023) & (US$ Million)
Table 103. Global ?-Nicotinamide Mononucleotide (NMN) Production Value by Application (2024-2029) & (US$ Million)
Table 104. Global ?-Nicotinamide Mononucleotide (NMN) Production Value Market Share by Application (2018-2023)
Table 105. Global ?-Nicotinamide Mononucleotide (NMN) Production Value Market Share by Application (2024-2029)
Table 106. Global ?-Nicotinamide Mononucleotide (NMN) Price by Application (2018-2023) & (US$/Kg)
Table 107. Global ?-Nicotinamide Mononucleotide (NMN) Price by Application (2024-2029) & (US$/Kg)
Table 108. Key Raw Materials
Table 109. Raw Materials Key Suppliers
Table 110. ?-Nicotinamide Mononucleotide (NMN) Distributors List
Table 111. ?-Nicotinamide Mononucleotide (NMN) Customers List
Table 112. ?-Nicotinamide Mononucleotide (NMN) Industry Trends
Table 113. ?-Nicotinamide Mononucleotide (NMN) Industry Drivers
Table 114. ?-Nicotinamide Mononucleotide (NMN) Industry Restraints
Table 115. Authors List of This Report
Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Content (2018 VS 2022 VS 2029) & (US$ Million)
Table 4. Market Value Comparison by Application (2018 VS 2022 VS 2029) & (US$ Million)
Table 5. Global ?-Nicotinamide Mononucleotide (NMN) Production by Manufacturers (Kg) & (2018-2023)
Table 6. Global ?-Nicotinamide Mononucleotide (NMN) Production Market Share by Manufacturers
Table 7. Global ?-Nicotinamide Mononucleotide (NMN) Production Value by Manufacturers (US$ Million) & (2018-2023)
Table 8. Global ?-Nicotinamide Mononucleotide (NMN) Production Value Market Share by Manufacturers (2018-2023)
Table 9. Global ?-Nicotinamide Mononucleotide (NMN) Average Price (US$/Kg) of Key Manufacturers (2018-2023)
Table 10. Global ?-Nicotinamide Mononucleotide (NMN) Industry Manufacturers Ranking, 2021 VS 2022 VS 2023
Table 11. Global ?-Nicotinamide Mononucleotide (NMN) Manufacturers, Product Type & Application
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global ?-Nicotinamide Mononucleotide (NMN) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value of 2022)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 15. GeneHarbor ?-Nicotinamide Mononucleotide (NMN) Company Information
Table 16. GeneHarbor Business Overview
Table 17. GeneHarbor ?-Nicotinamide Mononucleotide (NMN) Production Capacity (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 18. GeneHarbor Product Portfolio
Table 19. GeneHarbor Recent Developments
Table 20. Herbalmax ?-Nicotinamide Mononucleotide (NMN) Company Information
Table 21. Herbalmax Business Overview
Table 22. Herbalmax ?-Nicotinamide Mononucleotide (NMN) Production Capacity (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 23. Herbalmax Product Portfolio
Table 24. Herbalmax Recent Developments
Table 25. Genex Formulas ?-Nicotinamide Mononucleotide (NMN) Company Information
Table 26. Genex Formulas Business Overview
Table 27. Genex Formulas ?-Nicotinamide Mononucleotide (NMN) Production Capacity (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 28. Genex Formulas Product Portfolio
Table 29. Genex Formulas Recent Developments
Table 30. Shinkowa Pharmaceutical ?-Nicotinamide Mononucleotide (NMN) Company Information
Table 31. Shinkowa Pharmaceutical Business Overview
Table 32. Shinkowa Pharmaceutical ?-Nicotinamide Mononucleotide (NMN) Production Capacity (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 33. Shinkowa Pharmaceutical Product Portfolio
Table 34. Shinkowa Pharmaceutical Recent Developments
Table 35. Maac10 Formulas ?-Nicotinamide Mononucleotide (NMN) Company Information
Table 36. Maac10 Formulas Business Overview
Table 37. Maac10 Formulas ?-Nicotinamide Mononucleotide (NMN) Production Capacity (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 38. Maac10 Formulas Product Portfolio
Table 39. Maac10 Formulas Recent Developments
Table 40. EffePharm ?-Nicotinamide Mononucleotide (NMN) Company Information
Table 41. EffePharm Business Overview
Table 42. EffePharm ?-Nicotinamide Mononucleotide (NMN) Production Capacity (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 43. EffePharm Product Portfolio
Table 44. EffePharm Recent Developments
Table 45. Bontac ?-Nicotinamide Mononucleotide (NMN) Company Information
Table 46. Bontac Business Overview
Table 47. Bontac ?-Nicotinamide Mononucleotide (NMN) Production Capacity (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 48. Bontac Product Portfolio
Table 49. Bontac Recent Developments
Table 50. CELFULL ?-Nicotinamide Mononucleotide (NMN) Company Information
Table 51. CELFULL Business Overview
Table 52. CELFULL ?-Nicotinamide Mononucleotide (NMN) Production Capacity (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 53. CELFULL Product Portfolio
Table 54. CELFULL Recent Developments
Table 55. Kingdomway ?-Nicotinamide Mononucleotide (NMN) Company Information
Table 56. Kingdomway Business Overview
Table 57. Kingdomway ?-Nicotinamide Mononucleotide (NMN) Production Capacity (Kg), Value (US$ Million), Price (US$/Kg) and Gross Margin (2018-2023)
Table 58. Kingdomway Product Portfolio
Table 59. Kingdomway Recent Developments
Table 60. Global ?-Nicotinamide Mononucleotide (NMN) Production Comparison by Region: 2018 VS 2022 VS 2029 (Kg)
Table 61. Global ?-Nicotinamide Mononucleotide (NMN) Production by Region (2018-2023) & (Kg)
Table 62. Global ?-Nicotinamide Mononucleotide (NMN) Production Market Share by Region (2018-2023)
Table 63. Global ?-Nicotinamide Mononucleotide (NMN) Production Forecast by Region (2024-2029) & (Kg)
Table 64. Global ?-Nicotinamide Mononucleotide (NMN) Production Market Share Forecast by Region (2024-2029)
Table 65. Global ?-Nicotinamide Mononucleotide (NMN) Production Value Comparison by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 66. Global ?-Nicotinamide Mononucleotide (NMN) Production Value by Region (2018-2023) & (US$ Million)
Table 67. Global ?-Nicotinamide Mononucleotide (NMN) Production Value Market Share by Region (2018-2023)
Table 68. Global ?-Nicotinamide Mononucleotide (NMN) Production Value Forecast by Region (2024-2029) & (US$ Million)
Table 69. Global ?-Nicotinamide Mononucleotide (NMN) Production Value Market Share Forecast by Region (2024-2029)
Table 70. Global ?-Nicotinamide Mononucleotide (NMN) Market Average Price (US$/Kg) by Region (2018-2023)
Table 71. Global ?-Nicotinamide Mononucleotide (NMN) Consumption Comparison by Region: 2018 VS 2022 VS 2029 (Kg)
Table 72. Global ?-Nicotinamide Mononucleotide (NMN) Consumption by Region (2018-2023) & (Kg)
Table 73. Global ?-Nicotinamide Mononucleotide (NMN) Consumption Market Share by Region (2018-2023)
Table 74. Global ?-Nicotinamide Mononucleotide (NMN) Forecasted Consumption by Region (2024-2029) & (Kg)
Table 75. Global ?-Nicotinamide Mononucleotide (NMN) Forecasted Consumption Market Share by Region (2024-2029)
Table 76. North America ?-Nicotinamide Mononucleotide (NMN) Consumption Growth Rate by Country: 2018 VS 2022 VS 2029 (Kg)
Table 77. North America ?-Nicotinamide Mononucleotide (NMN) Consumption by Country (2018-2023) & (Kg)
Table 78. North America ?-Nicotinamide Mononucleotide (NMN) Consumption by Country (2024-2029) & (Kg)
Table 79. Europe ?-Nicotinamide Mononucleotide (NMN) Consumption Growth Rate by Country: 2018 VS 2022 VS 2029 (Kg)
Table 80. Europe ?-Nicotinamide Mononucleotide (NMN) Consumption by Country (2018-2023) & (Kg)
Table 81. Europe ?-Nicotinamide Mononucleotide (NMN) Consumption by Country (2024-2029) & (Kg)
Table 82. Asia Pacific ?-Nicotinamide Mononucleotide (NMN) Consumption Growth Rate by Country: 2018 VS 2022 VS 2029 (Kg)
Table 83. Asia Pacific ?-Nicotinamide Mononucleotide (NMN) Consumption by Country (2018-2023) & (Kg)
Table 84. Asia Pacific ?-Nicotinamide Mononucleotide (NMN) Consumption by Country (2024-2029) & (Kg)
Table 85. Latin America, Middle East & Africa ?-Nicotinamide Mononucleotide (NMN) Consumption Growth Rate by Country: 2018 VS 2022 VS 2029 (Kg)
Table 86. Latin America, Middle East & Africa ?-Nicotinamide Mononucleotide (NMN) Consumption by Country (2018-2023) & (Kg)
Table 87. Latin America, Middle East & Africa ?-Nicotinamide Mononucleotide (NMN) Consumption by Country (2024-2029) & (Kg)
Table 88. Global ?-Nicotinamide Mononucleotide (NMN) Production by Content (2018-2023) & (Kg)
Table 89. Global ?-Nicotinamide Mononucleotide (NMN) Production by Content (2024-2029) & (Kg)
Table 90. Global ?-Nicotinamide Mononucleotide (NMN) Production Market Share by Content (2018-2023)
Table 91. Global ?-Nicotinamide Mononucleotide (NMN) Production Market Share by Content (2024-2029)
Table 92. Global ?-Nicotinamide Mononucleotide (NMN) Production Value by Content (2018-2023) & (US$ Million)
Table 93. Global ?-Nicotinamide Mononucleotide (NMN) Production Value by Content (2024-2029) & (US$ Million)
Table 94. Global ?-Nicotinamide Mononucleotide (NMN) Production Value Market Share by Content (2018-2023)
Table 95. Global ?-Nicotinamide Mononucleotide (NMN) Production Value Market Share by Content (2024-2029)
Table 96. Global ?-Nicotinamide Mononucleotide (NMN) Price by Content (2018-2023) & (US$/Kg)
Table 97. Global ?-Nicotinamide Mononucleotide (NMN) Price by Content (2024-2029) & (US$/Kg)
Table 98. Global ?-Nicotinamide Mononucleotide (NMN) Production by Application (2018-2023) & (Kg)
Table 99. Global ?-Nicotinamide Mononucleotide (NMN) Production by Application (2024-2029) & (Kg)
Table 100. Global ?-Nicotinamide Mononucleotide (NMN) Production Market Share by Application (2018-2023)
Table 101. Global ?-Nicotinamide Mononucleotide (NMN) Production Market Share by Application (2024-2029)
Table 102. Global ?-Nicotinamide Mononucleotide (NMN) Production Value by Application (2018-2023) & (US$ Million)
Table 103. Global ?-Nicotinamide Mononucleotide (NMN) Production Value by Application (2024-2029) & (US$ Million)
Table 104. Global ?-Nicotinamide Mononucleotide (NMN) Production Value Market Share by Application (2018-2023)
Table 105. Global ?-Nicotinamide Mononucleotide (NMN) Production Value Market Share by Application (2024-2029)
Table 106. Global ?-Nicotinamide Mononucleotide (NMN) Price by Application (2018-2023) & (US$/Kg)
Table 107. Global ?-Nicotinamide Mononucleotide (NMN) Price by Application (2024-2029) & (US$/Kg)
Table 108. Key Raw Materials
Table 109. Raw Materials Key Suppliers
Table 110. ?-Nicotinamide Mononucleotide (NMN) Distributors List
Table 111. ?-Nicotinamide Mononucleotide (NMN) Customers List
Table 112. ?-Nicotinamide Mononucleotide (NMN) Industry Trends
Table 113. ?-Nicotinamide Mononucleotide (NMN) Industry Drivers
Table 114. ?-Nicotinamide Mononucleotide (NMN) Industry Restraints
Table 115. Authors List of This Report
LIST OF FIGURES
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. ?-Nicotinamide Mononucleotide (NMN)Product Picture
Figure 5. Market Value Comparison by Content (2018 VS 2022 VS 2029) & (US$ Million)
Figure 6. Above 98% Product Picture
Figure 7. Below 98% Product Picture
Figure 8. Health Care Products Product Picture
Figure 9. Cosmetics Product Picture
Figure 10. Others Product Picture
Figure . Global ?-Nicotinamide Mononucleotide (NMN) Production Value (US$ Million), 2018 VS 2022 VS 2029
Figure 1. Global ?-Nicotinamide Mononucleotide (NMN) Production Value (2018-2029) & (US$ Million)
Figure 2. Global ?-Nicotinamide Mononucleotide (NMN) Production Capacity (2018-2029) & (Kg)
Figure 3. Global ?-Nicotinamide Mononucleotide (NMN) Production (2018-2029) & (Kg)
Figure 4. Global ?-Nicotinamide Mononucleotide (NMN) Average Price (US$/Kg) & (2018-2029)
Figure 5. Global ?-Nicotinamide Mononucleotide (NMN) Key Manufacturers, Manufacturing Sites & Headquarters
Figure 6. Global ?-Nicotinamide Mononucleotide (NMN) Manufacturers, Date of Enter into This Industry
Figure 7. Global Top 5 and 10 ?-Nicotinamide Mononucleotide (NMN) Players Market Share by Production Valu in 2022
Figure 8. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 9. Global ?-Nicotinamide Mononucleotide (NMN) Production Comparison by Region: 2018 VS 2022 VS 2029 (Kg)
Figure 10. Global ?-Nicotinamide Mononucleotide (NMN) Production Market Share by Region: 2018 VS 2022 VS 2029
Figure 11. Global ?-Nicotinamide Mononucleotide (NMN) Production Value Comparison by Region: 2018 VS 2022 VS 2029 (US$ Million)
Figure 12. Global ?-Nicotinamide Mononucleotide (NMN) Production Value Market Share by Region: 2018 VS 2022 VS 2029
Figure 13. North America ?-Nicotinamide Mononucleotide (NMN) Production Value (US$ Million) Growth Rate (2018-2029)
Figure 14. Europe ?-Nicotinamide Mononucleotide (NMN) Production Value (US$ Million) Growth Rate (2018-2029)
Figure 15. China ?-Nicotinamide Mononucleotide (NMN) Production Value (US$ Million) Growth Rate (2018-2029)
Figure 16. Japan ?-Nicotinamide Mononucleotide (NMN) Production Value (US$ Million) Growth Rate (2018-2029)
Figure 17. Global ?-Nicotinamide Mononucleotide (NMN) Consumption Comparison by Region: 2018 VS 2022 VS 2029 (Kg)
Figure 18. Global ?-Nicotinamide Mononucleotide (NMN) Consumption Market Share by Region: 2018 VS 2022 VS 2029
Figure 19. North America ?-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2018-2029) & (Kg)
Figure 20. North America ?-Nicotinamide Mononucleotide (NMN) Consumption Market Share by Country (2018-2029)
Figure 21. United States ?-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2018-2029) & (Kg)
Figure 22. Canada ?-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2018-2029) & (Kg)
Figure 23. Europe ?-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2018-2029) & (Kg)
Figure 24. Europe ?-Nicotinamide Mononucleotide (NMN) Consumption Market Share by Country (2018-2029)
Figure 25. Germany ?-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2018-2029) & (Kg)
Figure 26. France ?-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2018-2029) & (Kg)
Figure 27. U.K. ?-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2018-2029) & (Kg)
Figure 28. Italy ?-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2018-2029) & (Kg)
Figure 29. Netherlands ?-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2018-2029) & (Kg)
Figure 30. Asia Pacific ?-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2018-2029) & (Kg)
Figure 31. Asia Pacific ?-Nicotinamide Mononucleotide (NMN) Consumption Market Share by Country (2018-2029)
Figure 32. China ?-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2018-2029) & (Kg)
Figure 33. Japan ?-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2018-2029) & (Kg)
Figure 34. South Korea ?-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2018-2029) & (Kg)
Figure 35. China Taiwan ?-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2018-2029) & (Kg)
Figure 36. Southeast Asia ?-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2018-2029) & (Kg)
Figure 37. India ?-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2018-2029) & (Kg)
Figure 38. Australia ?-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2018-2029) & (Kg)
Figure 39. Latin America, Middle East & Africa ?-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2018-2029) & (Kg)
Figure 40. Latin America, Middle East & Africa ?-Nicotinamide Mononucleotide (NMN) Consumption Market Share by Country (2018-2029)
Figure 41. Mexico ?-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2018-2029) & (Kg)
Figure 42. Brazil ?-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2018-2029) & (Kg)
Figure 43. Turkey ?-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2018-2029) & (Kg)
Figure 44. GCC Countries ?-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2018-2029) & (Kg)
Figure 45. Global ?-Nicotinamide Mononucleotide (NMN) Production Market Share by Content (2018-2029)
Figure 46. Global ?-Nicotinamide Mononucleotide (NMN) Production Value Market Share by Content (2018-2029)
Figure 47. Global ?-Nicotinamide Mononucleotide (NMN) Price (US$/Kg) by Content (2018-2029)
Figure 48. Global ?-Nicotinamide Mononucleotide (NMN) Production Market Share by Application (2018-2029)
Figure 49. Global ?-Nicotinamide Mononucleotide (NMN) Production Value Market Share by Application (2018-2029)
Figure 50. Global ?-Nicotinamide Mononucleotide (NMN) Price (US$/Kg) by Application (2018-2029)
Figure 51. ?-Nicotinamide Mononucleotide (NMN) Value Chain
Figure 52. ?-Nicotinamide Mononucleotide (NMN) Production Mode & Process
Figure 53. Direct Comparison with Distribution Share
Figure 54. Distributors Profiles
Figure 55. ?-Nicotinamide Mononucleotide (NMN) Industry Opportunities and Challenges
Highlights
The global ?-Nicotinamide Mononucleotide (NMN) market is projected to reach US$ million by 2028 from an estimated US$ million in 2022, at a CAGR of % during 2024 and 2029.
North American market for ?-Nicotinamide Mononucleotide (NMN) is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
Asia-Pacific market for ?-Nicotinamide Mononucleotide (NMN) is estimated to increase from $ million in 2022 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The major global companies of ?-Nicotinamide Mononucleotide (NMN) include GeneHarbor, Herbalmax, Genex Formulas, Shinkowa Pharmaceutical, Maac10 Formulas, EffePharm, Bontac, CELFULL and Kingdomway, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
The global market for ?-Nicotinamide Mononucleotide (NMN) in Health Care Products is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, Above 98%, which accounted for % of the global market of ?-Nicotinamide Mononucleotide (NMN) in 2022, is expected to reach million US$ by 2029, growing at a revised CAGR of % from 2023 to 2029.
Report Scope
This report aims to provide a comprehensive presentation of the global market for ?-Nicotinamide Mononucleotide (NMN), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding ?-Nicotinamide Mononucleotide (NMN).
The ?-Nicotinamide Mononucleotide (NMN) market size, estimations, and forecasts are provided in terms of output/shipments (Kg) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global ?-Nicotinamide Mononucleotide (NMN) market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the ?-Nicotinamide Mononucleotide (NMN) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
GeneHarbor
Herbalmax
Genex Formulas
Shinkowa Pharmaceutical
Maac10 Formulas
EffePharm
Bontac
CELFULL
Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. ?-Nicotinamide Mononucleotide (NMN)Product Picture
Figure 5. Market Value Comparison by Content (2018 VS 2022 VS 2029) & (US$ Million)
Figure 6. Above 98% Product Picture
Figure 7. Below 98% Product Picture
Figure 8. Health Care Products Product Picture
Figure 9. Cosmetics Product Picture
Figure 10. Others Product Picture
Figure . Global ?-Nicotinamide Mononucleotide (NMN) Production Value (US$ Million), 2018 VS 2022 VS 2029
Figure 1. Global ?-Nicotinamide Mononucleotide (NMN) Production Value (2018-2029) & (US$ Million)
Figure 2. Global ?-Nicotinamide Mononucleotide (NMN) Production Capacity (2018-2029) & (Kg)
Figure 3. Global ?-Nicotinamide Mononucleotide (NMN) Production (2018-2029) & (Kg)
Figure 4. Global ?-Nicotinamide Mononucleotide (NMN) Average Price (US$/Kg) & (2018-2029)
Figure 5. Global ?-Nicotinamide Mononucleotide (NMN) Key Manufacturers, Manufacturing Sites & Headquarters
Figure 6. Global ?-Nicotinamide Mononucleotide (NMN) Manufacturers, Date of Enter into This Industry
Figure 7. Global Top 5 and 10 ?-Nicotinamide Mononucleotide (NMN) Players Market Share by Production Valu in 2022
Figure 8. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 9. Global ?-Nicotinamide Mononucleotide (NMN) Production Comparison by Region: 2018 VS 2022 VS 2029 (Kg)
Figure 10. Global ?-Nicotinamide Mononucleotide (NMN) Production Market Share by Region: 2018 VS 2022 VS 2029
Figure 11. Global ?-Nicotinamide Mononucleotide (NMN) Production Value Comparison by Region: 2018 VS 2022 VS 2029 (US$ Million)
Figure 12. Global ?-Nicotinamide Mononucleotide (NMN) Production Value Market Share by Region: 2018 VS 2022 VS 2029
Figure 13. North America ?-Nicotinamide Mononucleotide (NMN) Production Value (US$ Million) Growth Rate (2018-2029)
Figure 14. Europe ?-Nicotinamide Mononucleotide (NMN) Production Value (US$ Million) Growth Rate (2018-2029)
Figure 15. China ?-Nicotinamide Mononucleotide (NMN) Production Value (US$ Million) Growth Rate (2018-2029)
Figure 16. Japan ?-Nicotinamide Mononucleotide (NMN) Production Value (US$ Million) Growth Rate (2018-2029)
Figure 17. Global ?-Nicotinamide Mononucleotide (NMN) Consumption Comparison by Region: 2018 VS 2022 VS 2029 (Kg)
Figure 18. Global ?-Nicotinamide Mononucleotide (NMN) Consumption Market Share by Region: 2018 VS 2022 VS 2029
Figure 19. North America ?-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2018-2029) & (Kg)
Figure 20. North America ?-Nicotinamide Mononucleotide (NMN) Consumption Market Share by Country (2018-2029)
Figure 21. United States ?-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2018-2029) & (Kg)
Figure 22. Canada ?-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2018-2029) & (Kg)
Figure 23. Europe ?-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2018-2029) & (Kg)
Figure 24. Europe ?-Nicotinamide Mononucleotide (NMN) Consumption Market Share by Country (2018-2029)
Figure 25. Germany ?-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2018-2029) & (Kg)
Figure 26. France ?-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2018-2029) & (Kg)
Figure 27. U.K. ?-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2018-2029) & (Kg)
Figure 28. Italy ?-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2018-2029) & (Kg)
Figure 29. Netherlands ?-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2018-2029) & (Kg)
Figure 30. Asia Pacific ?-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2018-2029) & (Kg)
Figure 31. Asia Pacific ?-Nicotinamide Mononucleotide (NMN) Consumption Market Share by Country (2018-2029)
Figure 32. China ?-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2018-2029) & (Kg)
Figure 33. Japan ?-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2018-2029) & (Kg)
Figure 34. South Korea ?-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2018-2029) & (Kg)
Figure 35. China Taiwan ?-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2018-2029) & (Kg)
Figure 36. Southeast Asia ?-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2018-2029) & (Kg)
Figure 37. India ?-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2018-2029) & (Kg)
Figure 38. Australia ?-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2018-2029) & (Kg)
Figure 39. Latin America, Middle East & Africa ?-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2018-2029) & (Kg)
Figure 40. Latin America, Middle East & Africa ?-Nicotinamide Mononucleotide (NMN) Consumption Market Share by Country (2018-2029)
Figure 41. Mexico ?-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2018-2029) & (Kg)
Figure 42. Brazil ?-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2018-2029) & (Kg)
Figure 43. Turkey ?-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2018-2029) & (Kg)
Figure 44. GCC Countries ?-Nicotinamide Mononucleotide (NMN) Consumption and Growth Rate (2018-2029) & (Kg)
Figure 45. Global ?-Nicotinamide Mononucleotide (NMN) Production Market Share by Content (2018-2029)
Figure 46. Global ?-Nicotinamide Mononucleotide (NMN) Production Value Market Share by Content (2018-2029)
Figure 47. Global ?-Nicotinamide Mononucleotide (NMN) Price (US$/Kg) by Content (2018-2029)
Figure 48. Global ?-Nicotinamide Mononucleotide (NMN) Production Market Share by Application (2018-2029)
Figure 49. Global ?-Nicotinamide Mononucleotide (NMN) Production Value Market Share by Application (2018-2029)
Figure 50. Global ?-Nicotinamide Mononucleotide (NMN) Price (US$/Kg) by Application (2018-2029)
Figure 51. ?-Nicotinamide Mononucleotide (NMN) Value Chain
Figure 52. ?-Nicotinamide Mononucleotide (NMN) Production Mode & Process
Figure 53. Direct Comparison with Distribution Share
Figure 54. Distributors Profiles
Figure 55. ?-Nicotinamide Mononucleotide (NMN) Industry Opportunities and Challenges
Highlights
The global ?-Nicotinamide Mononucleotide (NMN) market is projected to reach US$ million by 2028 from an estimated US$ million in 2022, at a CAGR of % during 2024 and 2029.
North American market for ?-Nicotinamide Mononucleotide (NMN) is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
Asia-Pacific market for ?-Nicotinamide Mononucleotide (NMN) is estimated to increase from $ million in 2022 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The major global companies of ?-Nicotinamide Mononucleotide (NMN) include GeneHarbor, Herbalmax, Genex Formulas, Shinkowa Pharmaceutical, Maac10 Formulas, EffePharm, Bontac, CELFULL and Kingdomway, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
The global market for ?-Nicotinamide Mononucleotide (NMN) in Health Care Products is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, Above 98%, which accounted for % of the global market of ?-Nicotinamide Mononucleotide (NMN) in 2022, is expected to reach million US$ by 2029, growing at a revised CAGR of % from 2023 to 2029.
Report Scope
This report aims to provide a comprehensive presentation of the global market for ?-Nicotinamide Mononucleotide (NMN), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding ?-Nicotinamide Mononucleotide (NMN).
The ?-Nicotinamide Mononucleotide (NMN) market size, estimations, and forecasts are provided in terms of output/shipments (Kg) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global ?-Nicotinamide Mononucleotide (NMN) market comprehensively. Regional market sizes, concerning products by types, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the ?-Nicotinamide Mononucleotide (NMN) manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.
Key Companies & Market Share Insights
In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
GeneHarbor
Herbalmax
Genex Formulas
Shinkowa Pharmaceutical
Maac10 Formulas
EffePharm
Bontac
CELFULL
